Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: SHUBLU who wrote (11412)	7/14/1998 2:36:00 AM
From: VLAD	Read Replies (2) \| Respond to of 23519

No chance. 1)ALZA doesn't have the money nor market exposure to sell MUSE in large volume and 2)Vivus would never sell itself for under $15.00/share--maybe $18.00 or $19.00 and even that is pushing it for Vivus.

To: SHUBLU who wrote (11412)	7/14/1998 9:46:00 AM
From: BigKNY3	Respond to of 23519

BLUSHU: <<Prediction: VVUS to be purchased by ALZA under $15.00, announced within 60 days >> BLU: Good point. It would be a logical choice since they now own the only US field force with trained experience with MUSE. The question I would raise is why didn't they complete the deal already? Either negotiations are still ongoing or Alza was more interested in a quick expansion of their field force to promote Alza's urological and oncology products rather than an interest in MUSE or buying VVUS. BigKNY3